Role of humanin, a mitochondrial-derived peptide, in cardiovascular disorders
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | Role of humanin, a mitochondrial-derived peptide, in cardiovascular disorders |
Type de publication | Journal Article |
Year of Publication | 2020 |
Auteurs | Rochette L, Meloux A, Zeller M, Cottin Y, Vergely C |
Journal | ARCHIVES OF CARDIOVASCULAR DISEASES |
Volume | 113 |
Pagination | 564-571 |
Date Published | AUG-SEP |
Type of Article | Review |
ISSN | 1875-2136 |
Mots-clés | Cardiovascular inflammation marker, Humanin, Mitochondrial-derived peptides |
Résumé | The mitochondria produce specific peptides-mitochondrial-derived peptides-that mediate the transcriptional stress response by their translocation into the nucleus and interaction with deoxyribonucleic acid. Mitochondrial-derived peptides are regulators of metabolism. This class of peptides comprises humanin, mitochondrial open reading frame of the 12S ribosomal ribonucleic acid type c (MOTS-c) and small humanin-like peptides (SHLPs). Humanin inhibits mitochondrial complex 1 activity and limits the level of oxidative stress in the cell. Data show that mitochondrial-derived peptides have a role in improving metabolic diseases, such as type 2 diabetes. Perhaps humanin can be used as a marker for mitochondrial function in cardiovascular disease or as a pharmacological strategy in patients with endothelial dysfunction. The goal of this review is to discuss the newly emerging functions of humanin, and its biological role in cardiovascular disorders. (C) 2020 Elsevier Masson SAS. All rights reserved. |
DOI | 10.1016/j.acvd.2020.03.020 |